Beximco Pharmaceuticals has a quick ratio of 0.83. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Beximco Pharmaceuticals's Quick Ratio or its related term are showing as below:
BXMPY'
s Quick Ratio Range Over the Past 10 Years
Min: 0.5 Med: 0.61 Max: 1.92
Current: 0.83
During the past 13 years, Beximco Pharmaceuticals's highest Quick Ratio was 1.92. The lowest was 0.50. And the median was 0.61.
BXMPY's Quick Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.45
vs BXMPY: 0.83
Beximco Pharmaceuticals (OTCPK:BXMPY) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Beximco Pharmaceuticals Quick Ratio Related Terms
Beximco Pharmaceuticals Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beximco Pharmaceuticals Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Beximco Pharmaceuticals's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Beximco Pharmaceuticals's Quick Ratio for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beximco Pharmaceuticals (BXMPY) has a Quick Ratio of 0.83 as of Dec. 2024. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Beximco Pharmaceuticals and its competitors. This is 36% above median its historical median of 0.61. Over the past decade, Beximco Pharmaceuticals' Quick Ratio has ranged from 0.50 to 1.92.
Is Beximco Pharmaceuticals' Quick Ratio too high?
Beximco Pharmaceuticals' current Quick Ratio of 0.83 is 36% above median its 10-year median of 0.61. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 1.92. The Drug Manufacturers industry median Quick Ratio is 1.45. Beximco Pharmaceuticals' value of 0.83 is 42.8% below this industry median. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Quick Ratio compare to ZTS and UTHR?
Beximco Pharmaceuticals' Quick Ratio of 0.83 can be compared against companies in the Drug Manufacturers industry. The industry median Quick Ratio is 1.45. Beximco Pharmaceuticals' value of 0.83 is 42.8% below this benchmark. Historically, Beximco Pharmaceuticals' own Quick Ratio has ranged from 0.50 to 1.92 over the past decade. While the company's 10-year median is 0.61 vs. the industry median of 1.45, Beximco Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beximco Pharmaceuticals's current Quick Ratio of 0.83 is 42.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Beximco Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beximco Pharmaceuticals's current Quick Ratio is 0.83, which is 36% above median its own 10-year median of 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Quick Ratio of 0.83. The current Quick Ratio is 0.83, which is 36% above median its 10-year median of 0.61 and 42.8% below the Drug Manufacturers industry median of 1.45. Beximco Pharmaceuticals' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Quick Ratio is 0.83 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXMPY has been successfully added to your 